In this issue of
Clinics in Laboratory Medicine, guest editors Drs. Olga Pozdnyakova and Carlo Brugnara bring their considerable expertise to the topic of
Hematology Laboratory in the Digital and Automation Age. Top experts in the field discuss how automation may be applied to hematology, coagulation, and flow cytometry; novel technologies for routine hematology and coagulation analysis to enhance readers knowledge of new digital technologies used for cell analysis and classification in hematology; and new uses of flow cytometry in the diagnosis of hematological malignancies, red cell disorders, and platelet function alterations.
- Contains 15 relevant, practice-oriented topics including automation in flow cytometry; immunodeficiency work-up by flow cytometry; routine coagulation; novel anticoagulants: laboratory aspects; and more.
- Provides in-depth clinical reviews on the hematology laboratory in the digital and automation age, offering actionable insights for clinical practice.
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Advances in Hematology Analyzers Technology
Screening of Myelodysplastic Syndromes Using Research Parameters of Complete Blood Count: Automated Detection of Dysplasia
Digital Imaging and AI Pre-classification in Hematology
Advances and Progress in Automated Urine Analyzers
Opportunities and Drawbacks of Digitalized Morphologic Analysis of Body Fluids
Advances in Bone Marrow Evaluation
Advances in Hemoglobinopathies and Thalassemia Evaluation
Automation in Flow Cytometry
Flow Cytometric Assessment of Malignant Hematologic Disorders
Flow Cytometry-based Immune Phenotyping of T and B Lymphocytes in the Evaluation of Immunodeficiency and Immune Dysregulation
Applications of Flow Cytometry in Diagnosis and Evaluation of Red Blood Cell Disorders
Flow Cytometry and Platelets
Routine Coagulation
Heparin Induced Thrombocytopenia Testing
Assessing Direct Oral Anticoagulants in the Clinical Laboratory
Carlo Brugnara is the Medical Director of Boston Children's Hospital & Department of Pathology, Harvard Medical School
